NY-ESO-1 (87-111) is an extended peptide fragment from the NY-ESO-1 cancer-testis antigen encompassing multiple overlapping epitopes. Its sequence supports peptide–MHC binding studies and conformational epitope mapping. Researchers employ it to analyze T-cell recognition across broader NY-ESO-1 segments. The peptide aids refined structural immunology of this highly immunogenic protein.
CAT No: M07039
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More